title: [Metformine induces false-positive (18)F-FDG PET/CT uptake].
authors.affiliation: Médecine interne, Groupe hospitalier Bichat-Claude Bernard, F-75877 Paris Cedex 18, France. benoit.brihaye@bch.aphp.fr
authors.forename: Benoît
authors.initials: B
authors.lastname: Brihaye
authors.forename: Olivier
authors.initials: O
authors.lastname: Lidove
authors.forename: David
authors.initials: D
authors.lastname: Lussato
authors.forename: Thomas
authors.initials: T
authors.lastname: Aparicio
authors.forename: Thomas
authors.initials: T
authors.lastname: Papo
mesh_terms: D003110:Colonic Neoplasms / Q000000981:diagnostic imaging*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005189:False Positive Reactions; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008687:Metformin / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D049268:Positron-Emission Tomography
chemical_list: D007004:Hypoglycemic Agents; D019788:Fluorodeoxyglucose F18; D008687:Metformin